AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity

Recruiting now

Conditions studied: Systemic Lupus Erythematosus Disease

In brief

This study aims to evaluate the clinical utility of combining the albumin to globulin ratio (AGR) and the prognostic nutritional index (PNI) as a predictive model for assessing disease activity in patients with systemic lupus erythematosus (SLE). By correlating these nutritional and inflammatory markers with clinical manifestations and laboratory parameters, we hope to establish a simple, non-invasive, and cost-effective tool to aid in monitoring disease activity in Systemic lupus erythematosus patients.

Key facts

Study ID

NCT07043153

Run by

Sohag University

People needed

200

Starts

2025-08-05

Expected to finish

2026-06-01

Last updated by the study team

2026-05-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• · Age ≥ 18 years.
• Both sexes.
• Patients diagnosed with SLE who fulfilling the Systemic Lupus International Collaborating Clinics (SLICC) classification criteria and matched controls.

You may not qualify if…

• Co-existing chronic inflammatory or autoimmune diseases.
• Age <18 years
• Malignancy.
• Pregnancy or lactation.
• Chronic liver or renal insufficiency.
• Malignant hematologic diseases.
• Active hepatitis.
• Acute infection within the previous four weeks

Where it is running

• Sohag University hospitals — Sohag, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.